RHYTHM PHARMACEUTICALS ANNOUNCES HEALTH CANADA APPROVAL OF IMCIVREE® (SETMELANOTIDE) FOR WEIGHT MANAGEMENT IN ADULT AND PEDIATRIC PATIENTS 4 YEARS OF AGE AND OLDER WITH ACQUIRED HYPOTHALAMIC OBESITY

Reuters · 1d ago

Please log in to view news